These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38927517)

  • 1. Mesenchymal Stem Cells and Purinergic Signaling in Autism Spectrum Disorder: Bridging the Gap between Cell-Based Strategies and Neuro-Immune Modulation.
    Wikarska A; Roszak K; Roszek K
    Biomedicines; 2024 Jun; 12(6):. PubMed ID: 38927517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem Cell-Derived Exosomes in Autism Spectrum Disorder.
    Alessio N; Brigida AL; Peluso G; Antonucci N; Galderisi U; Siniscalco D
    Int J Environ Res Public Health; 2020 Feb; 17(3):. PubMed ID: 32033002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem Cell Secretions as a Potential Therapeutic Agent for Autism Spectrum Disorder: A Narrative Review.
    Darwish M; El Hajj R; Khayat L; Alaaeddine N
    Stem Cell Rev Rep; 2024 Jul; 20(5):1252-1272. PubMed ID: 38630359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational use of mesenchymal stem cells in the treatment of autism spectrum disorders.
    Liu Q; Chen MX; Sun L; Wallis CU; Zhou JS; Ao LJ; Li Q; Sham PC
    World J Stem Cells; 2019 Feb; 11(2):55-72. PubMed ID: 30842805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell Therapies for Autism Spectrum Disorder Based on New Pathophysiology: A Review.
    Nabetani M; Mukai T; Taguchi A
    Cell Transplant; 2023; 32():9636897231163217. PubMed ID: 36999673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cells in autism spectrum and neurodevelopmental disorders: pitfalls and potential promises.
    Simberlund J; Ferretti CJ; Hollander E
    World J Biol Psychiatry; 2015 Sep; 16(6):368-375. PubMed ID: 26230216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-emerging concepts of immune dysregulation in autism spectrum disorders.
    Erbescu A; Papuc SM; Budisteanu M; Arghir A; Neagu M
    Front Psychiatry; 2022; 13():1006612. PubMed ID: 36339838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary Phytochemicals as Neurotherapeutics for Autism Spectrum Disorder: Plausible Mechanism and Evidence.
    Bhandari R; Paliwal JK; Kuhad A
    Adv Neurobiol; 2020; 24():615-646. PubMed ID: 32006377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of mTOR signaling mediates common neurite and migration defects in both idiopathic and 16p11.2 deletion autism neural precursor cells.
    Prem S; Dev B; Peng C; Mehta M; Alibutud R; Connacher RJ; St Thomas M; Zhou X; Matteson P; Xing J; Millonig JH; DiCicco-Bloom E
    Elife; 2024 Mar; 13():. PubMed ID: 38525876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zebrafish (Danio rerio) as a translational model for neuro-immune interactions in the enteric nervous system in autism spectrum disorders.
    Andersen-Civil AIS; Sawale RA; Vanwalleghem GC
    Brain Behav Immun; 2023 Aug; 112():254-266. PubMed ID: 37301234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma peroxiredoxin changes and inflammatory cytokines support the involvement of neuro-inflammation and oxidative stress in Autism Spectrum Disorder.
    Abruzzo PM; Matté A; Bolotta A; Federti E; Ghezzo A; Guarnieri T; Marini M; Posar A; Siciliano A; De Franceschi L; Visconti P
    J Transl Med; 2019 Oct; 17(1):332. PubMed ID: 31578139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adenosinergic pathway in mesenchymal stem cell fate and functions.
    Galgaro BC; Beckenkamp LR; van den M Nunnenkamp M; Korb VG; Naasani LIS; Roszek K; Wink MR
    Med Res Rev; 2021 Jul; 41(4):2316-2349. PubMed ID: 33645857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on Atypicalities of Central Nervous System in Autism Spectrum Disorder.
    Shuid AN; Jayusman PA; Shuid N; Ismail J; Kamal Nor N; Naina Mohamed I
    Brain Sci; 2020 May; 10(5):. PubMed ID: 32443912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential crosstalk between sonic hedgehog-WNT signaling and neurovascular molecules: Implications for blood-brain barrier integrity in autism spectrum disorder.
    Gozal E; Jagadapillai R; Cai J; Barnes GN
    J Neurochem; 2021 Oct; 159(1):15-28. PubMed ID: 34169527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-Based Molecules on Signaling Pathways in Autism Spectrum Disorder.
    Yui K; Imataka G; Yoshihara S
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cells in treating autism: Novel insights.
    Siniscalco D; Bradstreet JJ; Sych N; Antonucci N
    World J Stem Cells; 2014 Apr; 6(2):173-8. PubMed ID: 24772244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation and Neuro-Immune Dysregulations in Autism Spectrum Disorders.
    Siniscalco D; Schultz S; Brigida AL; Antonucci N
    Pharmaceuticals (Basel); 2018 Jun; 11(2):. PubMed ID: 29867038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of neuroinflammation in Autism Spectrum Disorder.
    Matta SM; Hill-Yardin EL; Crack PJ
    Brain Behav Immun; 2019 Jul; 79():75-90. PubMed ID: 31029798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Pathology and Pharmacological Treatment of Autism Spectrum Disorder-Like Phenotypes Using Rodent Models.
    Kuo HY; Liu FC
    Front Cell Neurosci; 2018; 12():422. PubMed ID: 30524240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal Cell Adhesion Molecules May Mediate Neuroinflammation in Autism Spectrum Disorder.
    Eve M; Gandawijaya J; Yang L; Oguro-Ando A
    Front Psychiatry; 2022; 13():842755. PubMed ID: 35492721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.